Legend Biotech Corp
Develops and commercializes CAR-T cell therapies for cancer, including CARVYKTI® for myeloma.
LEGN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US52490G1022
- LEI:
- Country:
- United States of America
- Address:
- 2101 COTTONTAIL LANE, 8873 SOMERSET
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Legend Biotech Corp is a global, commercial-stage biotechnology company specializing in the discovery, development, and manufacturing of novel cell therapies. The company is a pioneer in CAR-T cell therapy, primarily focused on treating cancer and other life-threatening diseases. Its flagship product is CARVYKTI® (ciltacabtagene autoleucel), a one-time treatment for relapsed or refractory multiple myeloma, which it develops and commercializes in collaboration with Johnson & Johnson. Legend Biotech is focused on building an end-to-end cell therapy company by maximizing patient access to CARVYKTI® and advancing a pipeline of innovative cell therapy modalities for future applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Legend Biotech Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Legend Biotech Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Legend Biotech Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
